Suppr超能文献

巴西的脆弱人群与结核病治疗结局。

Vulnerable populations and tuberculosis treatment outcomes in Brazil.

机构信息

Universidade Federal do Espírito Santo. Av. Fernando Ferrari 514, Goiabeiras. 29075-910 Vitória ES Brasil.

Universidade Estadual do Rio de Janeiro. Rio de Janeiro RJ Brasil.

出版信息

Cien Saude Colet. 2021 Oct;26(10):4749-4759. doi: 10.1590/1413-812320212610.24132020. Epub 2020 Aug 15.

Abstract

This article aims to assess the association between being a prisoner or homeless and treatment failure in cases of tuberculosis diagnosed in Brazil in 2015. We examined cases of tuberculosis in prisoners and the homeless in Brazil in 2015 reported to the national notifiable diseases information system using descriptive analysis and logistic regression. There were 82,056 cases of tuberculosis in 2015. Of these, 7,462 (10.3%) were prisoners and 2,782 (3.9%) were homeless. The rate of treatment success in prisoners was 78.6%, while the rate of failure in the homeless was 63.2%. Being a prisoner was a protective factor against treatment failure (adjusted odds ratio 0.68, 95%CI 0.63-0.73), while being homeless was a risk factor for treatment failure (adjusted odds ratio 2.38, 95%CI 2.17-2.61). Treatment success and failure rates differed between prisoners and the homeless. Our findings reinforce the need for public health policies tailored to the specific needs of these groups implemented in conjunction with social services and public security agencies in order to have a significant impact on TB incidence.

摘要

这篇文章旨在评估 2015 年在巴西诊断的结核病病例中囚犯和无家可归者与治疗失败之间的关联。我们使用描述性分析和逻辑回归检查了 2015 年巴西向国家传染病报告信息系统报告的囚犯和无家可归者的结核病病例。2015 年有 82056 例结核病。其中,7462 例(10.3%)为囚犯,2782 例(3.9%)为无家可归者。囚犯的治疗成功率为 78.6%,而无家可归者的治疗失败率为 63.2%。作为囚犯是治疗失败的保护因素(调整后的优势比为 0.68,95%CI 0.63-0.73),而无家可归者是治疗失败的风险因素(调整后的优势比为 2.38,95%CI 2.17-2.61)。囚犯和无家可归者的治疗成功率和失败率不同。我们的研究结果强调需要制定针对这些群体特定需求的公共卫生政策,并与社会服务和公共安全机构合作实施,以便对结核病发病率产生重大影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验